InvestorsHub Logo
Followers 1
Posts 42
Boards Moderated 0
Alias Born 03/01/2014

Re: None

Monday, 03/24/2014 7:09:35 PM

Monday, March 24, 2014 7:09:35 PM

Post# of 3835
Will this lower share price this news ?
•Galectin Therapeutics (GALT) files an S-3 for a $100M secondary offering of common stock plus 500,000 shares of common registered for sale by Richard Uihlein
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News